Lifesaving operations at risk say US surgeons
This article was originally published in Clinica
US surgeons have warned that they will be forced to stop performing accepted lifesaving procedures and instead use only "approved" - but more invasive, dangerous and costly - surgical techniques. At issue is a year-long US Department of Justice/Department of Health & Human Services Inspector General investigation into hospital billings for use of unapproved cardiac devices. The Justice Department issued 125 subpoenas last June, alleging that institutions charged Medicare and Medicaid programmes for these products even though US law forbids reimbursement until the devices are approved.
You may also be interested in...
A patent-litigation settlement that Teva has reached with Ironwood and Allergan over Linzess will allow the Israeli firm to enter the US market with the linaclotide-based constipation treatment ahead of major rivals Mylan, Sandoz, Sun Pharma and Aurobindo.
Following Aspen’s admission last year that it was party to an illegal, anti-competitive agreement on fludrocortisone, Tiofarma has now also conceded to the UK’s Competition and Markets Authority that it took part in the deal.